Status:
COMPLETED
MPA Pharmacokinetics in Renal Transplantation
Lead Sponsor:
University of Sao Paulo General Hospital
Conditions:
Kidney Transplantation Recipients
Eligibility:
All Genders
18-65 years
Brief Summary
Adequate exposure to mycophenolic acid (MPA) is associated with better outcomes in kidney transplantation. This study evaluated repeated, MPA pharmacokinetics (MPA-PK) according to post-transplant tim...
Eligibility Criteria
Inclusion
- Male and female patients aged 18-65 years, recipients of a non-HLA identical kidney allograft who presented a PRA \< 50% were eligible for the MoDIFY trial. Subjects were excluded if they received a non-renal organ, had current history of alcohol or illicit drug abuse, had liver enzymes more than two times the upper normal limit or received induction with anti-lymphocyte preparations.
Exclusion
Key Trial Info
Start Date :
September 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2005
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT01892761
Start Date
September 1 2002
End Date
June 1 2005
Last Update
July 4 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renal Transplantation Service
São Paulo, São Paulo, Brazil, 05403-900